Want to see APRE full AI Analyst Report?
ETFs with Aprea Therapeutics (APRE) Exposure
The following ETFs maintain exposure to Aprea Therapeutics (APRE). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
1 ETF Hold Aprea Therapeutics (APRE)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in APRE |
|---|---|---|---|---|---|---|
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $36.91K | 0.39% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in APRE |
|---|---|---|---|---|---|---|
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $36.91K | 0.39% |
Popular ETF Comparisons
APRE ETF Exposure FAQ
What ETFs hold Aprea Therapeutics stock?
Aprea Therapeutics (APRE) is currently held by 1 ETF in TipRanks’ ETF exposure database. The ETF(s) with exposure to APRE include Vanguard (VXF).
Which ETF has the largest exposure to APRE?
The ETF with the largest exposure to APRE is Vanguard (VXF), with approximately $36.91K in market value exposure.
How much APRE stock is held by ETFs?
ETFs currently hold approximately $36.91K worth of Aprea Therapeutics (APRE) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.